Filing Details

Accession Number:
0001209191-23-049751
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-18 16:22:58
Reporting Period:
2023-09-15
Accepted Time:
2023-09-18 16:22:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1699382 Pmv Pharmaceuticals Inc. PMVP Pharmaceutical Preparations (2834) 463218129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1825216 Leila Alland C/O Pmv Pharmaceuticals, Inc.
One Research Way
Princeton NJ 08540
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-09-15 6,291 $6.62 45,909 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.